Industry · AI News ·

Why biological data matters more in AI drug discovery

Why biological data matters more in AI drug discovery

GSK and Relation Therapeutics expanded their AI-assisted drug discovery collaboration in an agreement worth up to $110 million. Relation will generate large-scale datasets on cellular responses to genetic changes and drug interventions to train AI models.

Read the full story at AI News →